The half-life of most proteins in the body is about 10 minutes on average, and proteins entering the body are rapidly cleared by various proteases in the body. In particular, the complex tertiary and quaternary structures of protein drugs are easily denatured and inactivated during preparation and in vivo administration, and have very short half-lives. Facing the obstacles of enzymatic degradation in the gastrointestinal tract and the first-pass effect in the liver, the protein conformation is easily affected by the microenvironment such as acid-base and charge in the body, and after the conformation change, it not only loses its original activity, but also completely changes the nature of the protein, and even induces harmful immune reaction, making it change from a good drug to a poison. CD Formulation can customize the vesicles that encapsulate protein drug molecules to avoid the technical problems of drug rupture and leakage during in vivo delivery. Our technical team will perform a full range of analytical tests to ensure that the product meets your requirements and helps you develop your drug.
Among them, the protein macromolecule drug can be selected from one or more of B-galactosidase, FITC-BSA, calf serum protein, interferon or erythropoietin.
If you are interested in our services, please feel free to contact us.
Easy access to products and services you need from our library via powerful searching tools.